Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.21 USD | -4.33% | -4.28% | -3.66% |
Financials (USD)
Sales 2024 * | 2.71M | Sales 2025 * | 2.66M | Capitalization | 2.52B |
---|---|---|---|---|---|
Net income 2024 * | -153M | Net income 2025 * | -196M | EV / Sales 2024 * | 928 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 948 x |
P/E ratio 2024 * |
-16.5
x | P/E ratio 2025 * |
-13.3
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | -4.33% | ||
1 week | -4.28% | ||
Current month | +2.11% | ||
1 month | -0.83% | ||
3 months | -0.10% | ||
6 months | +31.35% | ||
Current year | -3.66% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.06% | 1,487 M€ | +9.17% | - | |
0.02% | 9 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 38.21 | -4.33% | 463,536 |
24-05-16 | 39.94 | -0.57% | 950,952 |
24-05-15 | 40.17 | +1.77% | 472,678 |
24-05-14 | 39.47 | -1.60% | 635,680 |
24-05-13 | 40.11 | +0.48% | 372,718 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.66% | 2.52B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- CLDX Stock